CA3040040C - Derives de 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline utiles dans le traitement du cancer - Google Patents

Derives de 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline utiles dans le traitement du cancer

Info

Publication number
CA3040040C
CA3040040C CA3040040A CA3040040A CA3040040C CA 3040040 C CA3040040 C CA 3040040C CA 3040040 A CA3040040 A CA 3040040A CA 3040040 A CA3040040 A CA 3040040A CA 3040040 C CA3040040 C CA 3040040C
Authority
CA
Canada
Prior art keywords
compound
methyl
pyrazolo
fluoropropyl
azetidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3040040A
Other languages
English (en)
Other versions
CA3040040A1 (fr
Inventor
James Stewart Scott
Bernard Christophe Barlaam
Bin Yang
Thomas Andrew MOSS
Samantha Jayne HUGHES
Johannes Wilhelmus Maria Nissink
Daniel Hillebrand O'DONOVAN
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority claimed from PCT/EP2017/076191 external-priority patent/WO2018077630A1/fr
Publication of CA3040040A1 publication Critical patent/CA3040040A1/fr
Application granted granted Critical
Publication of CA3040040C publication Critical patent/CA3040040C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des composés de formule (I) et des sels pharmaceutiquement acceptables de ceux-ci, des procédés et des intermédiaires utilisés pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation dans le traitement de troubles prolifératifs cellulaires.
CA3040040A 2016-10-24 2017-10-13 Derives de 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline utiles dans le traitement du cancer Active CA3040040C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662411799P 2016-10-24 2016-10-24
US62/411,799 2016-10-24
US201662435159P 2016-12-16 2016-12-16
US62/435,159 2016-12-16
PCT/EP2017/076191 WO2018077630A1 (fr) 2016-10-24 2017-10-13 Dérivés de 6,7,8,9-tétrahydro-3h-pyrazolo[4,3-f]isoquinoline utiles dans le traitement du cancer

Publications (2)

Publication Number Publication Date
CA3040040A1 CA3040040A1 (fr) 2018-05-03
CA3040040C true CA3040040C (fr) 2026-01-20

Family

ID=

Similar Documents

Publication Publication Date Title
US20240383895A1 (en) Chemical compounds
US10125135B2 (en) Chemical compounds
WO2018019793A1 (fr) Dérivés n-(2-(4-((1r,3r)-3-méthyl-2,3,4,9-tétrahydro-1h-pyrido [3,4-b]indol-1-yl)phénoxy) éthyl)propan-1-amine et composés associés en tant que régulateurs négatifs sélectifs du récepteur d'oestrogène pour le traitement du cancer
AU2018211495B2 (en) Estrogen receptor modulators
HK40026812A (en) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
HK40026812B (en) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer
HK40002601B (en) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivative useful in the treatment of cancer
HK40002601A (en) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivative useful in the treatment of cancer
RS62937B1 (sr) Derivati 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f]izohinolina korisni u tretmanu raka
EA037533B1 (ru) 6,7,8,9-ТЕТРАГИДРО-3H-ПИРАЗОЛО[4,3-f]ИЗОХИНОЛИНОВЫЕ ПРОИЗВОДНЫЕ, ПРИМЕНИМЫЕ В ЛЕЧЕНИИ РАКА
BR112019007393B1 (pt) Compostos 6,7,8,9-tetra-hidro-3h-pirazolo[4,3-]isoquinolina úteis no tratamento de câncer, uso dos mesmos, combinação, uso da combinação e composição farmaceutica
BR112019015389B1 (pt) Composto ácido (r)-3-((1r,3r)-1-(5-fluoro-2-(2-((3- fluoropropil)amino) etóxi)-3-metilpiridin-4-il)-3-metil1,3,4,9-tetra-hidro-2h-pirido[3,4-b]indol-2-il)-2- metilpropanoico, composição farmacêutica e uso do composto para tratamento de cancer de mama ou ginecológico